GHRH analog that stimulates your body's own growth hormone in a physiologic pattern.
Sermorelin is a growth-hormone-releasing hormone (GHRH) analog. Rather than replacing HGH, it stimulates the pituitary to release GH in its natural pulsatile rhythm — supporting sleep, recovery, body composition and cellular repair.
Nightly subcutaneous injection self-administered at bedtime. Onset is gradual; most patients report sleep improvement within 2 weeks and body-composition changes over 3–6 months.
Binds pituitary GHRH receptors, promoting endogenous GH release which drives hepatic IGF-1 production.
Not indicated in active malignancy. IGF-1 monitored quarterly. Injection-site reactions possible.
This page is educational and not medical advice. All VitaFlow protocols require evaluation by a licensed Florida physician.
Sermorelin stimulates your own natural pulsatile GH; HGH is exogenous and shuts down natural production.
Typically 3–6 months on, with breaks.
Sleep improvements within 2 weeks; body composition within 3+ months.
Mild injection-site reactions, occasional water retention early on.
Long-acting GHRH analog often paired with Ipamorelin for GH optimization.
Selective GH secretagogue with minimal impact on cortisol, prolactin or appetite.
FDA-approved GHRH analog with strong evidence for visceral fat reduction.
Meet with a VitaFlow physician to design a protocol tailored to your goals, biomarkers, and lifestyle.
